Impact of the COVID-19 pandemic on clinical trials: a cross-sectional questionnaire study in China.

ABSTRACT:

Background

The number of Chinese clinical trials has continued to grow throughout the coronavirus disease 2019 (COVID-19) pandemic, but we know little about clinical trial team members' perceptions and attitudes toward the impacts of the pandemic. This study aimed to assess the impact of the COVID-19 pandemic on clinical trials in China from the perspective of research staff to provide a deeper understanding and some recommendations for the ongoing and upcoming clinical trials during the pandemic.

Methods

A nationwide cross-sectional questionnaire was distributed to respondents throughout mainland China between September 2021 and October 2021. The participants assessed the impact of the COVID-19 pandemic on clinical trials based on a 5-point Likert-type scale, and explorator

SUBMITTER: Zhu Y 

PROVIDER: S-EPMC9708462 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature